BMRN vs PEAK
Biomarin Pharmaceutical Inc (BMRN) versus PEAK (PEAK) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
PEAK (PEAK) common stock.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
PEAK does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the BMRN and PEAK stock pages for the full models.
Not investment advice.